Global Rabies Diagnostics Market Size Study, by Method, by Technology, by End User and Regional Forecasts 2022-2032

Description

The Global Rabies Diagnostics Market was valued at approximately USD 2.11 Billion in 2023 and is projected to grow to around USD 3.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.21% during the forecast period from 2024 to 2032. Rabies diagnostics encompass several methods, including the Fluorescent Antibody Test (FAT), Direct Fluorescent Antibody (DFA) test, immunohistochemical tests, and amplification methods. This market is primarily driven by increased awareness and concern for animal-related diseases. Government initiatives to combat rabies, the growing necessity of immunization for humans and animals, and the development of surveillance strategies and diagnostic kits are significantly contributing to market expansion.

The rising incidence of neglected tropical diseases (NTDs) and the increasing number of dog bites are major drivers accelerating the growth of the rabies diagnostics market. The growing number of regulations related to rabies diagnosis, coupled with increasing healthcare expenditure and heightened awareness about the risks of virus exposure, further fuel market growth. Technological advancements in diagnostic methods and the launch of new products positively impact the market's growth rate. Additionally, rapid urbanization, changing lifestyles, and rising disposable incomes in both developing and developed countries significantly influence the growth trajectory of the rabies diagnostics market. Furthermore, collaborations among organizations for developing novel products and ongoing research to control rabies provide substantial growth opportunities. Increasing demand from emerging markets and government initiatives are anticipated to further propel market growth in the future. However, high diagnostic costs and increasing vaccination rates may hinder market growth. Intense competition among market players and the negative impact of COVID-19 on supply chains also present challenges. A lack of awareness regarding rabies diagnostics acts as a restraint, impeding market growth to some extent.

Asia-Pacific is expected to dominate the rabies diagnostics market during the forecast period, driven by improving healthcare infrastructure, rising investments in healthcare, and expansions by market players in the region. Countries like India and China are experiencing rapid growth due to government initiatives aimed at adopting new technologies and the best treatment options from developed countries. Moreover, the North America is anticipated to grow at fastest growth rate during forecast period 2024-2032.

Major market players included in this report are:

Bio-Rad Laboratories, Inc.
Merck KGaA
Aviva Systems Biology Corporation
Creative Diagnostics
Demeditec Diagnostics GmbH
Abbexa Ltd.
Norgen Biotek Corp.
BioNote, Inc.
Express Biotech International Inc.
MyBioSource.com

The detailed segments and sub-segments of the market are explained below:

By Method:

Fluorescent Antibody Test (FAT)
Immunohistochemical Test
Amplification Methods
Histologic Examination
Serology Tests

By Technology:

ELISA/Immunohistochemistry
Chromatography Techniques
PCR
Other

By End User:

Hospitals
Diagnostic Centers
Cancer Palliative Care Clinics
Others

By Region:

North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
Latin America
- Brazil
- Mexico
- RoLA
Middle East & Africa
- Saudi Arabia
- South Africa
- RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Rabies Diagnostics Market Executive Summary

1.1. Global Rabies Diagnostics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Method
- 1.3.2. By Technology
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Rabies Diagnostics Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Rabies Diagnostics Market Dynamics

3.1. Market Drivers
- 3.1.1. Increased Awareness and Concern for Animal-related Diseases
- 3.1.2. Rising Cases of Neglected Tropical Diseases (NTDs)
- 3.1.3. Increasing Healthcare Expenditure
3.2. Market Challenges
- 3.2.1. High Diagnostic Costs
- 3.2.2. Intense Market Competition
- 3.2.3. Negative Impact of COVID-19 on Supply Chains
3.3. Market Opportunities
- 3.3.1. Rise in Collaborations for Product Development
- 3.3.2. Increasing Demand from Emerging Markets
- 3.3.3. Government Initiatives to Combat Rabies

Chapter 4. Global Rabies Diagnostics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Rabies Diagnostics Market Size & Forecasts by Method 2022-2032

5.1. Segment Dashboard
5.2. Global Rabies Diagnostics Market: Method Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Fluorescent Antibody Test (FAT)
- 5.2.2. Immunohistochemical Test
- 5.2.3. Amplification Methods
- 5.2.4. Histologic Examination
- 5.2.5. Serology Tests

Chapter 6. Global Rabies Diagnostics Market Size & Forecasts by Technology 2022-2032

6.1. Segment Dashboard
6.2. Global Rabies Diagnostics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. ELISA/Immunohistochemistry
- 6.2.2. Chromatography Techniques
- 6.2.3. PCR
- 6.2.4. Other

Chapter 7. Global Rabies Diagnostics Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Global Rabies Diagnostics Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospitals
- 7.2.2. Diagnostic Centers
- 7.2.3. Cancer Palliative Care Clinics
- 7.2.4. Others

Chapter 8. Global Rabies Diagnostics Market Size & Forecasts by Region 2022-2032

8.1. North America Rabies Diagnostics Market
- 8.1.1. U.S. Rabies Diagnostics Market
  - 8.1.1.1. Method breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End User breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Rabies Diagnostics Market
8.2. Europe Rabies Diagnostics Market
- 8.2.1. U.K. Rabies Diagnostics Market
- 8.2.2. Germany Rabies Diagnostics Market
- 8.2.3. France Rabies Diagnostics Market
- 8.2.4. Spain Rabies Diagnostics Market
- 8.2.5. Italy Rabies Diagnostics Market
- 8.2.6. Rest of Europe Rabies Diagnostics Market
8.3. Asia-Pacific Rabies Diagnostics Market
- 8.3.1. China Rabies Diagnostics Market
- 8.3.2. India Rabies Diagnostics Market
- 8.3.3. Japan Rabies Diagnostics Market
- 8.3.4. Australia Rabies Diagnostics Market
- 8.3.5. South Korea Rabies Diagnostics Market
- 8.3.6. Rest of Asia Pacific Rabies Diagnostics Market
8.4. Latin America Rabies Diagnostics Market
- 8.4.1. Brazil Rabies Diagnostics Market
- 8.4.2. Mexico Rabies Diagnostics Market
- 8.4.3. Rest of Latin America Rabies Diagnostics Market
8.5. Middle East & Africa Rabies Diagnostics Market
- 8.5.1. Saudi Arabia Rabies Diagnostics Market
- 8.5.2. South Africa Rabies Diagnostics Market
- 8.5.3. Rest of Middle East & Africa Rabies Diagnostics Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Bio-Rad Laboratories, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Merck KGaA
- 9.3.3. Aviva Systems Biology Corporation
- 9.3.4. Creative Diagnostics
- 9.3.5. Demeditec Diagnostics GmbH
- 9.3.6. Abbexa Ltd.
- 9.3.7. Norgen Biotek Corp.
- 9.3.8. BioNote, Inc.
- 9.3.9. Express Biotech International Inc.
- 9.3.10. MyBioSource.com

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes